Adenosine and other low molecular weight factors released by muscle cells inhibit tumor cell growth

Cancer Research

Volumn 58, Issue 14, 1998, Pages 3181-3187

  Fishman, Pnina ^a   Bar Yehuda, Sara ^a   Vagman, Limor ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CARCINOMA; CANCER GROWTH; CANCER INHIBITION; CELL CYCLE; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; HUMAN; HUMAN CELL; LYMPHOMA CELL; MELANOMA; METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; RAT; SKELETAL MUSCLE;

EID: 0032527916     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Huffman, S. A., Paschkis, K. E., DeBias, D. A., Cantarow, A., and Williams, T. L. The influence of exercise on the growth of transplanted rat tumors. Cancer Res., 22: 597-599, 1991.
2. Baracos, V. E. Exercise inhibits progressive growth of the Morris hepatoma 7777 in male and female rats. Cancer J. Physiol. Pharmacol., 67: 864-870, 1989.
3. Giovannucci, E., Ascherio, A., Rimm, E. B., Colditz, G. A., Stampfer, M. J., and Willett, W. C. Physical activity obesity and risk for colon cancer and adenoma in men. Ann. Intern. Med., 122: 327-334, 1995.
4. Thune, I., Brenn, T., Lund, E., and Gaard, M. Physical activity and the risk of breast cancer. N. Engl. J. Med., 336: 1269-1275, 1997.
5. Sarma, D. P., Weilbaccher, T. G., and Love, G. L. Intramyofiber metastasis in skeletal muscle. J. Surg. Oncol., 30: 103-105, 1985.
6. Pellegrini, A. E. Carcinoma of the lung occurring as a skeletal muscle mass. Arch. Surg., 114: 550-555, 1979.
7. Merimsky, O., Levin, T., and Chaitchik, S. Recurrent solitary metastasis of renal cell carcinoma in skeletal muscles. Tumori, 76: 407-409, 1990.
8. Djaldetti, M., Sredni, B., Zigelman, R., Verber, M., and Fishman, P. Muscle cells produce a low molecular weight factor with anti-cancer activity. Clin. Exp. Matastasis, 14: 189-196, 1996.
9. Pines, M., Ashkenazi, A., Cohen-Chapnik, L., Binder, L., and Gertler, A. Inhibition of the proliferation of Nb2 cells by femtomolar concentrations of cholera toxin and partial reversal of the effect by 12-O-tetradecanoyl-phorbol-13-acetate. J. Cell. Biochem., 37: 119-129, 1988.
10. Terada, M., Fujiki, H., Marks, P. A., and Sugimura, T. Induction of erythroid differentiation of murine erythroleukemia cells by nicotinamide and related compounds. Proc. Natl. Acad. Sci. USA, 76: 6411-6414, 1979.
11. Krishan, A. Rapid flow cytofluorometric analysis of mammalian cell cycle by propidium iodide staining. J. Cell Biol., 66: 188-193, 1975.
12. Husmann, I., Soulet, L., Gautron. J., Martelly, I., and Barritault, D. Growth factors in skeletal muscle regeneration. Cytokine Growth Factor Rev., 7: 249-258, 1996.
13. Birnbaum, M., Trink, B., Shainberg, A., and Salzberg, S. Activation of the Interferon system during myogenesis in vitro. Differentiation, 45: 138-145, 1990.
14. Rosztoczy, I., Megyeri, K., and Papos, M. Interferon production by normal mouse tissues in organ cultures. Interferon Res., 9: 509-515, 1989.
15. Kurek, J. B., Nouri, S., Kannourakis, G., Murphy, M., and Austin, L. Leukemia inhibitory factor and interleukin-6 are produced by diseased and regenerating skeletal muscle. Muscle Nerve, 19: 1291-1301, 1996.
16. Lafyatis, R., Lechleider, R., Roberts, A. B., and Sporn, M. B. Secretion of transcriptional regulation of transforming growth factor-β3 during myogenesis. Mol. Cell. Biol., 7: 3795-3803, 1991.
17. Berne, R. M. The role of adenosine in the regulation of coronary blood flow. Circ. Res., 47: 807-813, 1980.
18. Dobson, J. G., Jr. Mechanism of adenosine inhibition of catecholamine-induced responses in heart. Circ. Res., 52: 151-160, 1983.
19. Collis, M. G. The vasodilator role of adenosine. Pharmacol. Ther. 41: 143-162, 1989.
20. Soderback, U., Sollevi, A., Vallen, V. H., Larsson, P. T., and Hjemdahl, P. Antiaggregatory effects of physiological concentrations of adenosine in human whole blood as assessed by filtragometry. Clin. Sci., 81: 691-694, 1991.
21. Paul, P., Rothmann, S. A., and Meagher, R. C. Modulation of erythropoietin production by adenosine. J. Lab. Clin. Med., 112: 168-173, 1988.
22. Elgler, A., Greten, T. F., Sinha, B., Haslberger, C., Sullivan, G. W., and Endres, S. Endogenous adenosine curtails lipopolysaccharide-stimulated tumor necrosis factor synthesis. Scand. J. Immunol., 45: 132-139, 1997.
23. Bouma, M. G., Stad, R. D., van den Wildenber, F. A. J. M., and Buurman, W. A. Differential regulatory effects of adenosine on cytokine release by activated human monocytes. J. Immunol., 153: 4159-4168, 1994.
24. Bajaj, S. L., Insel, J., Quagliata, F., Hirschhorn, R., and Silber, R. Adenosine and adenosine analogues are more toxic to chronic lymphocytic leukemia than to normal lymphocytes. Blood, 62: 75-80, 1983.
25. Tey, H. B., Khoo, H. E., and Tan, C. H. Adenosine modulates cell growth in human epidermoid carcinoma (A431) cells. Biochem. Biophys. Res. Commun., 187; 1486-1492, 1992.
26. Khoo, H-E., Ho, C-L. A., Vikram, J. S., Chatwal, B., Steven, T. F., Chan, B., Sing-Shang Ngoi, B., Shabbir, M., and Moochhala, B. Differential expression of adenosine A1 receptors in colorectal cancer and related mucosa. Cancer Lett., 106: 17-21, 1996.
27. Rapaport, E. Experimental cancer therapy in mice by adenine nucleotides. Eur. J. Cancer Clin. Oncol., 24: 1491-1497, 1988.
28. Rapaport, E., and Fontaine, J. Anticancer activities of adenine nucleotides in mice are mediated through expansion of erythrocyte ATP pools. Proc. Natl. Acad. Sci. USA, 86: 1662-1666, 1989.
29. Stiles, G. L. Adenosine receptors. J. Biol. Chem., 267: 6451-6454, 1992.
30. Griffiths, M., Beaumont, N., Yao, S. Y., Sundaram, M., Boumah, C. E., Davies, A., Kwong, F. Y., Coe, I., Cass, C. E., Young, J. D., and Baldwin, S. A. Cloning of a human nucleoside transporter implicated in the cellular uptake of adenosine and chemotherapeutic drugs. Nat. Med., 3: 89-93, 1997.
31. Vives-Corrons, J. L., Rozman, M. A. Pujades, D., Colomer, E., Perez-Vila, I., Anegon, T., Gallart, J., Vives-Puiggros, N., Vinolas, B., and Montserrat, E. Combined assay of adenosine deaminase, purine nucleoside phosphorylase, and lactate dehydrogenase in the early clinical evaluation of B-chronic lymphocytic leukemia. Am. J. Hematol., 27: 157-162, 1988.
32. Murray, J. L., Loftin, K. C., Munn, C. G., Reuben, J. M., Mansell, P. W. A., and Hersh, E. M. Elevated adenosine deaminase and purine nucleotide phosphorylase in peripheral blood null lymphocytes from patients with acquired immune deficiency syndrome. Blood, 65: 1318-1324, 1985.
33. Tominaga, S., Curnish, R. R., Belardinelli, L., Rubio, R., and Berne, R. M. Adenosine release during early and sustained exercise of canine skeletal muscle. Am. J. Physiol., 238: 156-163, 1980.
34. Parkinson, P. I. The effect of graduated exercise on the concentration of adenine nucleotides in plasma. J. Physiol. (Lond.), 234: 72-74, 1973.